Cell & Gene Therapy Innovation · the Circle
The science has moved. The constraint is no longer biological. The room exists to close the gap between what is possible and what reaches the patient.
the Why
01
Cell and gene therapy has crossed from experimental to clinical. Multiple modalities are approved. The constraint now is not the biology — it is the system that delivers the biology to the patient.
02
Manufacturing scalability, supply chain resilience, reimbursement architecture and regulatory coherence remain unsolved at the scale the field demands. The delay costs lives.
03
These problems are not solved by working groups, white papers or conference panels. They are solved when the people with institutional authority to make decisions are in the same room, aligned.
04
CGTI is closed. Invite-only. No audience, no broadcast, no performative Q&A. The conversation is structured around decisions, not presentations. The room is the mechanism.
Advisory
Advisory faculty are confirmed practitioners — operators, scientists and executives who have navigated the cell and gene therapy system at scale. Their presence is a signal of the room's quality.
Faculty name
on confirmation
Role · Department
Organisation
Faculty name
on confirmation
Role · Department
Organisation
Faculty name
on confirmation
Role · Department
Organisation
Advisory grid populated on receipt of confirmed faculty CSV (published records only).
Venue · Berlin
Hotel Palace Berlin is positioned at the intersection of institutional weight and operational precision — the character the Circle requires of every venue it convenes in.
The forum occupies dedicated event space across two days. Closed to external foot traffic. The room is the room.
Budapester Strasse 45 · 10787 Berlin · Germany
Co-located with BILS 2027 · MEVO 2027
For the patients. We must do better.
Request access